Platinum Investment Management LTD Prometheus Biosciences, Inc. Transaction History

Platinum Investment Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$103.46 - $126.29 $3.55 Million - $4.33 Million	-34,270 Reduced 12.89%	231,521 $24.8 Million
Q4 2022 Feb 13, 2023	SELL	$36.06 - $117.21 $3.16 Million - $10.3 Million	-87,565 Reduced 24.78%	265,791 $29.2 Million
Q3 2022 Nov 14, 2022	SELL	$28.17 - $59.01 $2.2 Million - $4.62 Million	-78,211 Reduced 18.12%	353,356 $20.9 Million
Q1 2022 May 13, 2022	SELL	$30.13 - $50.0 $2.71 Million - $4.5 Million	-89,962 Reduced 17.25%	431,567 $16.3 Million
Q4 2021 Feb 11, 2022	BUY	$22.28 - $39.54 $423,520 - $751,615	19,009 Added 3.78%	521,529 $20.6 Million
Q3 2021 Nov 09, 2021	BUY	$20.89 - $26.96 $3.08 Million - $3.98 Million	147,619 Added 41.59%	502,520 $11.9 Million
Q2 2021 Aug 11, 2021	BUY	$16.8 - $29.65 $3.59 Million - $6.34 Million	213,753 Added 151.44%	354,901 $8.72 Million
Q1 2021 May 13, 2021	BUY	$16.51 - $25.29 $2.33 Million - $3.57 Million	141,148 New	141,148 $2.58 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.